CN114286866A - 用于扩增和检测包括从cccDNA转录的HBV RNA在内的乙型肝炎病毒RNA的组合物和方法 - Google Patents

用于扩增和检测包括从cccDNA转录的HBV RNA在内的乙型肝炎病毒RNA的组合物和方法 Download PDF

Info

Publication number
CN114286866A
CN114286866A CN202080060613.8A CN202080060613A CN114286866A CN 114286866 A CN114286866 A CN 114286866A CN 202080060613 A CN202080060613 A CN 202080060613A CN 114286866 A CN114286866 A CN 114286866A
Authority
CN
China
Prior art keywords
hbv
nucleic acid
primers
seq
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080060613.8A
Other languages
English (en)
Chinese (zh)
Inventor
J·方
A·T·汉密尔顿
M·黑尔
I·科兹洛夫
E·G·马林斯
E·M·斯科特
L·王
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN114286866A publication Critical patent/CN114286866A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/161Modifications characterised by incorporating target specific and non-target specific sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/114Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ecology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202080060613.8A 2019-08-27 2020-02-24 用于扩增和检测包括从cccDNA转录的HBV RNA在内的乙型肝炎病毒RNA的组合物和方法 Pending CN114286866A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962892132P 2019-08-27 2019-08-27
US62/892132 2019-08-27
PCT/EP2020/054715 WO2021037399A1 (en) 2019-08-27 2020-02-24 Compositions and methods for amplification and detection of hepatitis b virus rna, including hbv rna transcribed from cccdna

Publications (1)

Publication Number Publication Date
CN114286866A true CN114286866A (zh) 2022-04-05

Family

ID=69701185

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080060613.8A Pending CN114286866A (zh) 2019-08-27 2020-02-24 用于扩增和检测包括从cccDNA转录的HBV RNA在内的乙型肝炎病毒RNA的组合物和方法

Country Status (6)

Country Link
US (1) US11739382B2 (https=)
EP (1) EP4022086B1 (https=)
JP (1) JP7677950B2 (https=)
CN (1) CN114286866A (https=)
ES (1) ES3039650T3 (https=)
WO (1) WO2021037399A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119433101A (zh) * 2024-11-28 2025-02-14 郑州安图生物工程股份有限公司 用于定量扩增和检测血清或血浆中hbv rna的引物组和方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4022086B1 (en) 2019-08-27 2025-08-06 F. Hoffmann-La Roche AG Compositions and methods for amplification and detection of hepatitis b virus rna, including hbv rna transcribed from cccdna
US20220275465A1 (en) * 2019-08-27 2022-09-01 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR AMPLIFICATION AND DETECTION OF HEPATITIS B VIRUS RNA, INCLUDING HBV RNA TRANSCRIBED FROM cccDNA
CN115125334A (zh) * 2022-06-29 2022-09-30 广州达安基因股份有限公司 一种乙型肝炎病毒rna检测试剂盒及方法
CN119452103A (zh) * 2022-09-02 2025-02-14 学校法人北里研究所 评估幽门螺旋杆菌除菌后的患者罹患胃癌的风险的方法、多核苷酸和试剂盒
CN117512209A (zh) * 2023-09-20 2024-02-06 南方医科大学南方医院 一种检测hbv剪接型rna的引物和探针组合物及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135587B2 (en) 1983-02-22 2002-12-18 Syngene, Inc. Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4996143A (en) 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5683896A (en) 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
EP1067134B1 (en) 1991-11-07 2004-07-28 Nanotronics, Inc. Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
JP3451667B2 (ja) 1993-08-24 2003-09-29 東ソー株式会社 核酸抽出及び特定核酸配列の検出方法
JP4540754B2 (ja) 1996-06-04 2010-09-08 ユニバーシティ オブ ユタ リサーチ ファウンデーション Pcr中のハイブリダイゼーションのモニタリング
ES2253778T3 (es) 1996-06-04 2006-06-01 University Of Utah Research Foundation Sistema y metodos de monitorizacion de una amplificacion de adn mediante fluorescencia.
EP0866071B1 (en) 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modified primers
US20040058314A1 (en) 2002-05-29 2004-03-25 Ming Liang He Assay for the detection and quantification of HBV cccDNA by real-time PCR
JP4386660B2 (ja) 2003-03-25 2009-12-16 株式会社先端生命科学研究所 Hbv−rnaを含むhbv粒子
US20120045747A1 (en) 2010-08-23 2012-02-23 Samsung Techwin Co., Ltd. Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using the same
EP1783211A4 (en) 2004-06-22 2007-08-08 Advanced Life Science Inst Inc HBV PARTICLE WITH HBV RNA
ES2371088T3 (es) 2005-10-05 2011-12-27 F. Hoffmann-La Roche Ag Transferencia de energía no fluorescente.
US8962293B2 (en) 2006-10-18 2015-02-24 Roche Molecular Systems, Inc. DNA polymerases and related methods
US20090220969A1 (en) 2007-09-28 2009-09-03 North Carolina State University Identifying and quantifying small RNAs
KR101822609B1 (ko) * 2010-06-24 2018-01-26 주식회사 파나진 Pna 기반의 실시간 pcr 클램핑을 이용한 마이크로rna 발현양상의 분석 방법 및 키트
US9175332B2 (en) * 2010-07-29 2015-11-03 Roche Molecular Systems, Inc. Generic PCR
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
WO2014052487A1 (en) 2012-09-28 2014-04-03 Cepheid Two-primer pcr for microrna multiplex assay
CN104884636B (zh) 2012-10-30 2018-09-18 新加坡科技研究局 Hbv对肝细胞癌癌症患者临床结果的影响
CN103898100B (zh) * 2012-12-26 2017-09-22 深圳先进技术研究院 cccDNA标准品及其制备方法、定量检测乙肝病毒cccDNA的方法及试剂盒
EP3052644B1 (en) 2013-10-01 2019-07-10 Texcell Detection of rare microbiological nucleic acids
KR101830700B1 (ko) 2013-11-11 2018-02-21 주식회사 파나진 클램핑 프로브 및 검출 프로브를 이용한 다중 표적핵산 검출방법
CN104372106A (zh) * 2014-09-05 2015-02-25 徐州市传染病医院 一种LAMP法检测石蜡包埋肝组织中HBV cccDNA的引物和试剂盒
CN104388598B (zh) 2014-12-11 2016-08-24 上海五色石医学研究有限公司 一种HBV cccDNA数字PCR定量检测试剂盒及其应用
US11248255B2 (en) * 2015-06-19 2022-02-15 The Governing Council Of The University Of Toronto Amplification of nanoparticle based assay
CN108603226A (zh) * 2016-02-15 2018-09-28 Jbs科学公司 乙型肝炎病毒cccdna的定量测量
EA202091646A1 (ru) * 2018-01-05 2020-11-17 Квошент Сюисс Са Платформа на основе самособирающегося диагностического массива
EP4022086B1 (en) 2019-08-27 2025-08-06 F. Hoffmann-La Roche AG Compositions and methods for amplification and detection of hepatitis b virus rna, including hbv rna transcribed from cccdna

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119433101A (zh) * 2024-11-28 2025-02-14 郑州安图生物工程股份有限公司 用于定量扩增和检测血清或血浆中hbv rna的引物组和方法

Also Published As

Publication number Publication date
EP4022086C0 (en) 2025-08-06
JP2022546443A (ja) 2022-11-04
ES3039650T3 (en) 2025-10-23
WO2021037399A1 (en) 2021-03-04
JP7677950B2 (ja) 2025-05-15
US20210062259A1 (en) 2021-03-04
US11739382B2 (en) 2023-08-29
EP4022086A1 (en) 2022-07-06
EP4022086B1 (en) 2025-08-06

Similar Documents

Publication Publication Date Title
JP7677950B2 (ja) cccDNAから転写されたHBV RNAを含む、B型肝炎ウイルスRNAの増幅および検出のための組成物および方法
JP6911190B2 (ja) バベシア(Babesia)の検出のための組成物及び方法
CN109983138B (zh) 用于检测bk病毒的组合物和方法
JP7478734B2 (ja) カンジダ・アウリス(candida auris)の検出のための組成物および方法
CN108779500B (zh) 用于检测寨卡病毒的组合物和方法
US20220275465A1 (en) COMPOSITIONS AND METHODS FOR AMPLIFICATION AND DETECTION OF HEPATITIS B VIRUS RNA, INCLUDING HBV RNA TRANSCRIBED FROM cccDNA
JP6117775B2 (ja) スタフィロコッカス・アウレウスの検出のための組成物及び方法
JP2024517835A (ja) 二重標的アッセイによりデルタ型肝炎ウイルスを検出するための組成物及び方法
CN116615563A (zh) 用于检测疟疾的组合物和方法
US10370731B2 (en) Compositions and methods for detection of hepatitis C virus genotype 3
JP6999645B2 (ja) 核酸の増幅及び検出/定量の効率を改良するためのヘルパーオリゴヌクレオチド
CN120457216A (zh) 针对多个乙型肝炎病毒基因靶标的数字pcr测定设计及用于其的不可延伸的阻断剂寡核苷酸
JP7628085B2 (ja) 鎖分離温度に基づくDNAに対してRNA標的の優先的/選択的増幅のためのdITPの利用
CN117441029A (zh) 用于检测具有刺突蛋白突变的严重急性呼吸综合征冠状病毒2(sars-cov-2)变体的组合物和方法
US11028451B2 (en) Compositions and methods for detection of Mycobacterium tuberculosis
CN118202069A (zh) 用于检测疟疾的组合物和方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination